Status:
COMPLETED
Patient Reported Outcomes and Patient Education in Cellular Therapy Patients
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Conditions:
Stem Cell Transplant
CAR T-Cell Transplant
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this research is to provide an educational visit addressing common emotional stressors involved in the transplant/CAR-T process, and determine if this added education improves levels of...
Detailed Description
Individuals who decide to participate in this study, will be provided with a survey evaluating current symptoms. This survey should take approximately 10 minutes to complete. Individuals will then be...
Eligibility Criteria
Inclusion
- Any patient with an underlying hematologic disease planning to undergo an autologous or allogeneic hematopoietic stem cell transplant (HSCT) or chimeric antigen receptor T-cell (CAR-T) therapy at Dartmouth-Hitchcock Medical Center is eligible.
- The patient must be approved for HSCT/CAR-T by the treating transplant physician.
- This includes completion of their pre-treatment work up and consent as directed by the standard DHMC SOPs.
- \- Age \>18 years, and no upper age limit
Exclusion
- Any patient with medical, social, or psychological factors that would prevent the patient from cooperating with the trial and completing surveys at requested intervals.
Key Trial Info
Start Date :
February 7 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 29 2023
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04853277
Start Date
February 7 2021
End Date
March 29 2023
Last Update
November 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756